Research output per year
Research output per year
Research output
- 21 results
Search results
-
2024
The prognostic and potentially immunomodulatory role of cartilage oligomeric matrix protein in patients with gastric and esophageal adenocarcinoma
Papadakos, K. S., Gorji-Bahri, G., Gialeli, C., Hedner, C., Hagerling, C., Svensson, M. C., Jeremiasen, M., Borg, D., Fristedt, R., Jirström, K. & Blom, A. M., 2024 Apr 2, In: Cancer Immunology Immunotherapy. 73, 5, 93.Research output: Contribution to journal › Article › peer-review
Open Access -
2023
Impact of Laparoscopic Gastrectomy on the Completion Rate of the Perioperative Chemotherapy Regimen in Gastric Cancer: A Swedish Nationwide Study
Tsekrekos, A., Borg, D., Johansson, V., Nilsson, M., Klevebro, F., Lundell, L., Gustafsson-Liljefors, M. & Rouvelas, I., 2023 Nov, In: Annals of Surgical Oncology. 30, 12, p. 7196-7205 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers
Mezheyeuski, A., Backman, M., Mattsson, J., Martín-Bernabé, A., Larsson, C., Hrynchyk, I., Hammarström, K., Ström, S., Ekström, J., Mauchanski, S., Khelashvili, S., Lindberg, A., Agnarsdóttir, M., Edqvist, P. H., Huvila, J., Segersten, U., Malmström, P.-U., Botling, J., Nodin, B. & Hedner, C. & 10 others, , 2023, In: EBioMedicine. 88, p. 1-18 104452.Research output: Contribution to journal › Article › peer-review
Open Access -
2022
High infiltration of CD68+/CD163- macrophages is an adverse prognostic factor after neoadjuvant chemotherapy in esophageal and gastric adenocarcinoma
Svensson, M. C., Svensson, M., Nodin, B., Borg, D., Hedner, C., Hjalmarsson, C., Leandersson, K. & Jirström, K., 2022, In: Journal of Innate Immunity. 14, 6 , p. 615-628Research output: Contribution to journal › Article › peer-review
Open Access -
2021
T cells, B cells, and PD-L1 expression in esophageal and gastric adenocarcinoma before and after neoadjuvant chemotherapy: relationship with histopathological response and survival
Svensson, M. C., Lindén, A., Nygaard, J., Borg, D., Hedner, C., Nodin, B., Leandersson, K. & Jirström, K., 2021 May 20, In: OncoImmunology. 10, 1, 14 p., 1921443.Research output: Contribution to journal › Article › peer-review
-
Development of a novel weighted ranking method for immunohistochemical quantification of a heterogeneously expressed protein in gastro-esophageal cancers
Richards, C. E., Sheehan, K. M., Kay, E. W., Hedner, C., Borg, D., Fay, J., O’grady, A., Hill, A. D. K., Jirström, K. & Hopkins, A. M., 2021, In: Cancers. 13, 6, 12 p., 1286.Research output: Contribution to journal › Article › peer-review
Open Access -
The prognostic impact of the tumour stroma fraction: A machine learning-based analysis in 16 human solid tumour types
Micke, P., Strell, C., Mattsson, J., Martín-Bernabé, A., Brunnström, H., Huvila, J., Sund, M., Wärnberg, F., Ponten, F., Glimelius, B., Hrynchyk, I., Mauchanski, S., Khelashvili, S., Garcia-Vicién, G., Molleví, D. G., Edqvist, P. H., O´Reilly, A., Corvigno, S., Dahlstrand, H. & Botling, J. & 17 others, , 2021, In: EBioMedicine. 65, 103269.Research output: Contribution to journal › Article › peer-review
Open Access -
2020
Tumor-Associated CD68+, CD163+, and MARCO+ Macrophages as Prognostic Biomarkers in Patients With Treatment-Naïve Gastroesophageal Adenocarcinoma
Jeremiasen, M., Borg, D., Hedner, C., Svensson, M., Nodin, B., Leandersson, K., Johansson, J. & Jirström, K., 2020 Oct 23, In: Frontiers in Oncology. 10, 534761.Research output: Contribution to journal › Article › peer-review
Open Access -
Palliative short-course hypofractionated radiotherapy followed by chemotherapy in esophageal adenocarcinoma: the phase II PALAESTRA trial
Borg, D., Sundberg, J., Brun, E., Kjellén, E., Petersson, K., Hermansson, M., Johansson, J., Eberhard, J. & Johnsson, A., 2020, In: Acta Oncologica. 59, 2, p. 212-218 7 p.Research output: Contribution to journal › Article › peer-review
Open Access -
2019
Expression of PD-L1 and PD-1 in chemoradiotherapy-Naïve esophageal and gastric adenocarcinoma: Relationship with mismatch repair status and survival
Svensson, M. C., Borg, D., Zhang, C., Hedner, C., Nodin, B., Uhlén, M., Mardinoglu, A., Leandersson, K. & Jirström, K., 2019 Mar 13, In: Frontiers in Oncology. 9, MAR, 136.Research output: Contribution to journal › Article › peer-review
Open Access -
2018
Expression and prognostic significance of human epidermal growth factor receptors 1, 2 and 3 in oesophageal and gastric adenocarcinomas preneoadjuvant and postneoadjuvant treatment
Hedner, C., Borg, D., Nodin, B., Karnevi, E., Jirström, K. & Eberhard, J., 2018 May 1, In: Journal of Clinical Pathology. 71, 5, p. 451-462 12 p.Research output: Contribution to journal › Article › peer-review
-
Podocalyxin-like protein as a predictive biomarker for benefit of neoadjuvant chemotherapy in resectable gastric and esophageal adenocarcinoma
Borg, D., Larsson, A. H., Hedner, C., Nodin, B., Johnsson, A. & Jirström, K., 2018, In: Journal of Translational Medicine. 16, 1, 290.Research output: Contribution to journal › Article › peer-review
Open Access -
2017
The integrative clinical impact of tumor-infiltrating T lymphocytes and NK cells in relation to B lymphocyte and plasma cell density in esophageal and gastric adenocarcinoma
Svensson, M. C., Warfvinge, C. F., Fristedt, R., Hedner, C., Borg, D., Eberhard, J., Micke, P., Nodin, B., Leandersson, K. & Jirström, K., 2017 Sept 22, In: Oncotarget. 8, 42, p. 72108-72126 19 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): A multicentre, open-label, randomised, phase 3 trial
Neoptolemos, J. P., Palmer, D. H., Ghaneh, P., Psarelli, E. E., Valle, J. W., Halloran, C. M., Faluyi, O., O'Reilly, D. A., Cunningham, D., Wadsley, J., Darby, S., De Meyer, T., Gillmore, R., Anthoney, A., Lind, P., Glimelius, B., Falk, S., Izbicki, J. R., Middleton, G. W. & Cummins, S. & 14 others, , 2017, In: The Lancet. 389, 10073, p. 1011-1024Research output: Contribution to journal › Article › peer-review
Open Access -
2016
Pancreatic cancer: Yesterday, today and tomorrow
Ansari, D., Tingstedt, B., Andersson, B., Holmquist, F., Sturesson, C., Williamsson, C., Sasor, A., Borg, D., Bauden, M. & Andersson, R., 2016 Aug 1, In: Future Oncology. 12, 16, p. 1929-1946 18 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Expression of podocalyxin-like protein is an independent prognostic biomarker in resected esophageal and gastric adenocarcinoma
Borg, D., Hedner, C., Nodin, B., Larsson, A., Johnsson, A., Eberhard, J. & Jirström, K., 2016 Jul 29, In: BMC Clinical Pathology. 16, 1, 13.Research output: Contribution to journal › Article › peer-review
Open Access -
Expression and Prognostic Significance of Human Epidermal Growth Factor Receptors 1 and 3 in Gastric and Esophageal Adenocarcinoma.
Hedner, C., Borg, D., Nodin, B., Karnevi, E., Jirström, K. & Eberhard, J., 2016, In: PLoS ONE. 11, 2, e0148101.Research output: Contribution to journal › Article › peer-review
Open Access -
Expression of IFITM1 as a prognostic biomarker in resected gastric and esophageal adenocarcinoma
BORG, D., Hedner, C., Gaber, A., Nodin, B., Fristedt, R., Jirström, K., Eberhard, J. & Johnsson, A., 2016, In: Biomarker research. 4, 10.Research output: Contribution to journal › Article › peer-review
Open Access -
Prognostic impact of tumour-associated B cells and plasma cells in oesophageal and gastric adenocarcinoma
Fristedt, R., Borg, D., Hedner, C., Berntsson, J., Nodin, B., Eberhard, J., Micke, P. & Jirström, K., 2016, In: Journal of Gastrointestinal Oncology. 7, 6, p. 848-859 12 p.Research output: Contribution to journal › Article › peer-review
-
2015
Discordant HER2 overexpression in primary and metastatic upper gastrointestinal adenocarcinoma signifies poor prognosis.
Hedner, C., Tran, L., Borg, D., Nodin, B., Jirström, K. & Eberhard, J., 2015, In: Histopathology.Research output: Contribution to journal › Article › peer-review
-
2009
Experiences from treatment-predictive KRAS testing; high mutation frequency in rectal cancers from females and concurrent mutations in the same tumor
Jönsson, M., Isinger Ekstrand, A., Edekling, T., Eberhard, J., Grabau, D., Borg, D. & Nilbert, M., 2009 Oct 15, In: BMC Clinical Pathology. 9, Oct 15, p. 8 8.Research output: Contribution to journal › Article › peer-review
File295 Downloads (Pure)